Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report

Pharmacol Toxicol. 2002 May;90(5):243-5. doi: 10.1034/j.1600-0773.2002.900503.x.

Abstract

We report a case of a 39-year-old male with bipolar affective disorder who was admitted to hospital with an intentional acute lithium intoxication resulting in renal insufficiency. The patient had previously been treated with lithium, risperidone, fluoxetine and lorazepam, and successfully titrated to lithium levels of 0.7 mmol/l. After overdosing, the lithium level was 5.89 mmol/l and haemodialysis was initiated. A full pharmacokinetic time profile of lithium was obtained. After successful haemodialysis treatment, lithium levels recovered below toxic levels of 1.5 mmol/l in 53 hr. Without intervention non-toxic levels were not expected to have been reached within 6 days, based on computer simulation of predialysis levels. The patient was discharged 6 days after admission without residual symptoms. It was concluded that the lithium intoxication resulted from a combination of lithium overdose and subsequent renal insufficiency due to the overdose. A possible fluoxetine-risperidone interaction was not considered clinically apparent.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / therapy
  • Adult
  • Antimanic Agents / blood
  • Antimanic Agents / pharmacokinetics*
  • Antimanic Agents / poisoning*
  • Antipsychotic Agents / therapeutic use
  • Bayes Theorem
  • Bipolar Disorder / drug therapy*
  • Drug Therapy, Combination
  • Fluoxetine / therapeutic use
  • Humans
  • Lithium / blood
  • Lithium / pharmacokinetics*
  • Lithium / poisoning*
  • Lorazepam / therapeutic use
  • Male
  • Models, Biological
  • Renal Dialysis
  • Risperidone / therapeutic use
  • Suicide, Attempted

Substances

  • Antimanic Agents
  • Antipsychotic Agents
  • Fluoxetine
  • Lithium
  • Risperidone
  • Lorazepam